tweenvest

Hamlet BioPharma AB (publ) (XSAT: HAMLET B)

Health Care · Biotechnology · SE

Skr6.08

+1.67% today · +26.3% 1Y

Public summary
A free snapshot of Hamlet BioPharma AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Hamlet BioPharma AB (publ) (XSAT: HAMLET B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $113.40M.

Over the last twelve months the share price has gained 26.3%, trading between 4.36 and 8.96.

Tweenvest scores Hamlet BioPharma AB (publ) across four factors: quality 30/100, value 80/100. Its strongest factor is value.

HAMLET B price history

Nov 21, 2025 · 4.95Weekly closes 4.95 – 8.83Sep 30, 2026 · 6.08

Key figures

Market cap
$113.40M
Revenue (TTM)
$5.64K
P/E
-19.10
EPS
-0.30
Dividend yield
—
Beta (5Y)
0.35
52-week high
Skr8.96
52-week low
Skr4.36
Avg volume (3M)
—
Shares outstanding
186.18M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Actinogen Medical LimitedASX: ACW$117.91MAU$0.05-4.26%
Minerva Neurosciences, Inc.NasdaqCM: NERV$114.62M$2.30-3.36%
Upstream Bio, Inc.NasdaqGS: UPB$114.01M$2.08-0.95%
Aroa Biosurgery LimitedASX: ARX$113.78MAU$0.49-2.97%
BNC KOREA, Inc.KOSDAQ: A256840$113.23M₩2,210.00-1.78%
GC Cell CorporationKOSDAQ: A144510$112.30M₩9,990.00-2.15%
Nykode Therapeutics ASOB: NYKD$110.50MNkr2.740.00%
ArcticZymes Technologies ASAOB: AZT$110.39MNkr21.10+0.48%

Browse every Biotechnology company →